596 - Immunogenicity and Safety of BPZE1, an Intranasal Live Attenuated Pertussis Vaccine, Evaluated With and Without Tdap in Healthy Children 6 to 17 Years Old: A Phase 2b, Randomized, Active-Controlled Study

Saturday, October 19, 2024

2:45 PM – 3:00 PM US PT

Location: 403 B

Co-Author(s)

Saul N. Faust, FRCPCH PhD (he/him/his)

Professor of Paediatric Immunology and Infectious Diseases
University of Southampton and University Hospital Southampton NHS Foundation Trust
Southampton, England, United Kingdom

Co-Author(s)

JC

Javier Céspedes, MD

Clinica San Agustin
San Jose, San Jose, Costa Rica
LA

Lydiana Avila, MD

Instituto de Investigación de Ciencias Médicas
San Jose, San Jose, Costa Rica

Presenting Author(s)

Gabriela Ivankovich-Escoto, MD

Pediatric Immunologist
Metropolitano Research Institute
San Jose, San Jose, Costa Rica

Slides

Co-Author(s)

HM

Helen Marshall, MD

University of Adelaide
Adelaide, South Australia, Australia
PR

Peter Richmond, MBBS

University of Western Australia School of Medicine, Perth’s Children Hospital
Nedlands, Western Australia, Australia
Terry Nolan, MD, PhD (he/him/his)

Head of Vaccine & Immunisation Research Group (VIRGo)
The Peter Doherty Institute for Infection and Immunity, Murdoch Children’s Research Institute
Melbourne, Victoria, Australia
JB

Jolanta Bernatoniene, FRCPCH PhD

Consultant in Paediatric Infectious Disease and Immunology
University Hospitals Bristol & Weston NHS Foundation Trust, Bristol Royal Hospital For Children
Bristol, England, United Kingdom
SB

Srini Bandi, MD

Leicester Children's Hospital
Leicester, England, United Kingdom
AS

Anil Shenoy, FRCPCH

Bradford Royal Infirmary
Bradford, England, United Kingdom
LW

Lisa Weissfeld, PhD

WCG Clinical
Princeton, New Jersey, United States
WL

Wei Lang, PhD

Director, Biostatistics
WCG Clinical
Princeton, New Jersey, United States
CL

Camille Locht, PhD

Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017–CIIL - Centre for Infection and Immunity of Lille
Lille, Haute-Normandie, France
VS

Vivek Samal, MD

ILiAD Biotechnologies
Weston, Florida, United States
PG

Peter Goldstein, n/a

ILiAD Biotechnologies
Weston, Florida, United States
KS

Ken Solovay, n/a

ILiAD Biotechnologies
Weston, Florida, United States
KR

Keith Rubin, MD

Chief Executive Officer
ILiAD Biotechnologies
Weston, Florida, United States
SN

Stephanie Noviello, MD, MPH

ILiAD Biotechnologies
Weston, Florida, United States

Disclosure(s):

Saul N. Faust, FRCPCH PhD: AstraZeneca: Grant/Research Support; BioNTech: Grant/Research Support; GSK: Grant/Research Support; Iliad Biotechnologies: Grant/Research Support; J&J: Advisor, no personal payments (all honoraria paid to employing hospital), Grant/Research Support; Moderna: Grant/Research Support; Novavax: Advisor, no personal payments (all honoraria paid to employing hospital); Pfizer: Advisor, no personal payments (all honoraria paid to employing hospital); Sanofi: Advisor, no personal payments (all honoraria paid to employing hospital), Grant/Research Support; Valneva: Grant/Research Support

Javier Céspedes, MD: ILiAD Biotechnologies: Grant/Research Support

Lydiana Avila, MD: ILiAD biotechnologies: Grant/Research Support

Gabriela Ivankovich-Escoto, MD: Iliad: Honoraria

Helen Marshall, MD: ILiAD biotechnologies: Grant/Research Support

Peter Richmond, MBBS: ILiAD biotechnologies: Grant/Research Support

Terry Nolan, MD, PhD: ILiAD biotechnologies: Grant/Research Support

Jolanta Bernatoniene, FRCPCH PhD: Iliad Biotechnologies: Grant/Research Support

Srini Bandi, MD: Iliad Biotechnologies: Grant/Research Support

Anil Shenoy, FRCPCH: Iliad Biotechnologies: Grant/Research Support

Lisa Weissfeld, PhD: No financial relationships to disclose

Wei Lang, PhD: No financial relationships to disclose

Camille Locht, PhD: ILiAD biotechnologies: Advisor/Consultant, Grant/Research Support

Vivek Samal, MD: No financial relationships to disclose

Peter Goldstein, n/a: ILiAD Biotechnologies LLC: Employee, Stocks/Bonds (Private Company)

Ken Solovay, n/a: ILiAD biotechnologies: Employee, Stocks/Bonds (Private Company)

Keith Rubin, MD: ILiAD Biotechnologies: Board Member, Ownership Interest, Stocks/Bonds (Private Company)

Stephanie Noviello, MD, MPH: ILiAD Biotechnologies: Employee, Stocks/Bonds (Private Company)